Did NEU make a mistake by indicating that they would not be prepared to consider any offers until after the FDA meeting?
Has that been the catalyst for the $10 decline in the SP?
Did giving potential acquirers that information allow them to subsequently control the situation and potentially drop an acceptable t/o price by $1 billion+?
I just have the feeling that NEU is not as firmly planted in the drivers seat as should be the case given the NNZ2591 results.
Did NEU make a mistake by indicating that they would not be...
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.14 |
Change
-0.130(0.85%) |
Mkt cap ! $1.935B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $7.335M | 485.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7079 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.17 | 3189 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |